by Dover, Delaware — Delaware has introduced a groundbreaking health policy aimed at preventing food allergies in babies. Starting January 1, 2026, the state became the first in the United States to require insurance companies and Medicaid to fully cover doctor-prescribed allergen supplements for infants, eliminating out-of-pocket costs for families.
The new law allows parents to access peanut and egg allergen supplements for babies between 4 and 6 months old, as long as they are prescribed by a licensed healthcare provider. Lawmakers and health advocates say the initiative is designed to reduce the likelihood of children developing severe food allergies later in life.
Law designed to remove financial barriers
The legislation was introduced by State Rep. Kimberly Williams as House Bill 274 in January 2024.
After receiving unanimous approval from a House committee in March, the bill was later signed into law by Gov. John Carney on August 29, 2024.
The law requires insurers and Medicaid programs to cover prescribed infant allergen supplements with no copays or deductibles.
Coverage applies to health insurance plans issued or renewed after December 31, 2025, including both individual and group policies regulated under Delaware law.
Advocacy groups such as Food Allergy Research & Education (FARE) and the Allergy and Asthma Network supported the legislation.
Research shows early exposure can reduce allergies
The policy is largely based on scientific findings from a landmark study published in The New England Journal of Medicine in 2015, known as the LEAP study.
Researchers followed 640 infants considered at high risk for peanut allergies over several years.
Babies who consumed peanut-containing foods between 4 and 11 months old were more than 80% less likely to develop a peanut allergy by age five.
The study was partly inspired by observations in Israel, where peanut allergies were much less common because babies frequently eat a peanut-based snack called Bamba.
Benefits appear to last into adolescence
Additional research has strengthened the evidence supporting early allergen introduction.
A follow-up study called LEAP-Trio, published in 2025 and funded by the National Institutes of Health, tracked the same children into their teenage years.
Children who were introduced to peanuts early remained protected from peanut allergies even into adolescence.
Researchers found the protective effect persisted even if children did not consistently consume peanut products later in childhood.
These findings suggested the benefits of early exposure may be long-lasting rather than temporary.
Food allergy diagnoses already declining
Real-world health data has also shown promising trends.
A 2025 study from the Children’s Hospital of Philadelphia, published in the journal Pediatrics, analyzed medical records from more than 120,000 children.
After early introduction guidelines were adopted, peanut allergy diagnoses dropped by 43% in children under age three.
The study also found overall food allergy diagnoses declined by 36% during the same period.
Researchers estimated that introducing allergens early in about 200 infants may prevent one child from developing a food allergy.
Approach does not eliminate all risks
Despite the strong research, experts emphasize that early allergen exposure is not guaranteed to prevent allergies in every child.
In the original LEAP study, roughly one in five high-risk infants still developed a peanut allergy despite early exposure.
Some studies conducted in countries such as Australia and Sweden have also shown mixed results after guideline changes.
Medical experts advise parents to consult a pediatrician before introducing allergen products to infants.
Surveys suggest that only about 29% of pediatricians consistently follow early introduction guidelines, highlighting the need for continued education.
Cost has been a major barrier for families
Advocates say cost has been one of the main reasons families have not followed early allergen introduction recommendations.
Allergen supplement products can be expensive without insurance coverage, leaving many families hesitant to try them.
Delaware’s new law removes the financial barrier by making these supplements free for insured families and those covered by Medicaid.
The legislation also includes public education initiatives designed to help parents better understand allergy prevention strategies.
Program cost considered modest compared to allergy treatment
The fiscal estimate attached to the bill projects the program will cost about $640,000 in fiscal year 2027.
Supporters argue that preventing allergies could save significantly more in the long term.
Read Also: Why Filling Up in California Costs So Much More Than the Rest of the U.S.
According to FARE, food allergies cost U.S. families roughly $33 billion each year, including medical care, special foods, and related expenses.
Approximately 8% of children in the United States have at least one food allergy.
Health advocates say prevention strategies could significantly reduce long-term medical and social costs.
What Delaware families should know
Parents in Delaware can now access allergen supplements for infants through a prescription from a licensed healthcare provider.
The law defines eligible infants as children under 1 year old, with doctors typically recommending introduction between 4 and 6 months of age.
Medical professionals still encourage families to discuss their child’s individual health history and readiness before starting allergen exposure.
The coverage applies to both individual and group health insurance plans regulated within Delaware, ensuring many families can access the benefit.
Do you think more states should offer free allergy prevention supplements for infants? Share your thoughts respectfully in the comments below.
